HBM Bioventures exits Asthmatx for $193m – AltAssets


Daily Rosetta

HBM Bioventures exits Asthmatx for $193m
AltAssets
Swiss venture capital firm HBM Bioventures has sold asthma medical device company Asthmatx to medical technology company Boston Scientific for $193.5m,
Boston Scientific to Buy Asthmatx for $193.5 Million Gaining Asthma DeviceBloomberg
Boston Sci to buy Asthmatx for more than $193 mlnReuters
Boston Scientific Acquiring Maker of Non-Drug Asthma TreatmentFOXBusiness
Wall Street Journal –Zacks.com –Mass High Tech
all 138 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *